Don’t Do Different Things…Do Things Differently! Drug Development in Rare Diseases

Michelle Rudek-Renaut, J. M. Korth-Bradley

Research output: Contribution to journalComment/debatepeer-review

Abstract

Although definitions of rare disease vary, most acknowledge that there are small numbers of affected patients compared with other conditions. Small numbers of patients, overlapping involvement of investigators as researchers and caregivers, as well as close relationships between researchers and manufacturers require a different pattern of drug development. Regulatory guidances for rare diseases are available, as well as ones for specific rare diseases. Maintaining drug supply for rare diseases also demands innovative approaches.

Original languageEnglish (US)
Pages (from-to)333-335
Number of pages3
JournalClinical Pharmacology and Therapeutics
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Don’t Do Different Things…Do Things Differently! Drug Development in Rare Diseases'. Together they form a unique fingerprint.

Cite this